Garlo KG - Search Results

1

Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts.

Shah SN, Amato MG, Garlo KG, Seger DL, Bates DW. Shah SN, et al. Among authors: garlo kg. J Am Med Inform Assoc. 2021 Jun 12;28(6):1081-1087. doi: 10.1093/jamia/ocaa222. J Am Med Inform Assoc. 2021. PMID: 33517413 Free PMC article.

2

Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.

Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM. Garlo KG, et al. JAMA Netw Open. 2018 Nov 2;1(7):e183874. doi: 10.1001/jamanetworkopen.2018.3874. JAMA Netw Open. 2018. PMID: 30646338 Free PMC article.

3

Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease.

Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM. Garlo KG, et al. Medicine (Baltimore). 2019 Dec;98(49):e17963. doi: 10.1097/MD.0000000000017963. Medicine (Baltimore). 2019. PMID: 31804307 Free PMC article.

4

Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation.

Mavrakanas TA, Garlo K, Charytan DM. Mavrakanas TA, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1146-1154. doi: 10.2215/CJN.11650919. Epub 2020 May 22. Clin J Am Soc Nephrol. 2020. PMID: 32444398 Free PMC article.

5

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease.

Garlo KG, Steele DJR, Nigwekar SU, Chan KE. Garlo KG, et al. Clin J Am Soc Nephrol. 2019 Jan 7;14(1):125-136. doi: 10.2215/CJN.06430518. Epub 2018 Dec 28. Clin J Am Soc Nephrol. 2019. PMID: 30593489 Free PMC article. Review.

6

Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.

Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM. Garlo KG, et al. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):398-405. doi: 10.2215/CJN.05280517. Epub 2018 Jan 16. Clin J Am Soc Nephrol. 2018. PMID: 29339356 Free PMC article.

7

Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study.

Garlo K, Williams D, Lucas L, Wong R, Botler J, Abramson S, Parker MG. Garlo K, et al. Medicine (Baltimore). 2015 Jun;94(25):e964. doi: 10.1097/MD.0000000000000964. Medicine (Baltimore). 2015. PMID: 26107682 Free PMC article.

8

Burden in caregivers of older adults with advanced illness.

Garlo K, O'Leary JR, Van Ness PH, Fried TR. Garlo K, et al. J Am Geriatr Soc. 2010 Dec;58(12):2315-22. doi: 10.1111/j.1532-5415.2010.03177.x. Epub 2010 Nov 18. J Am Geriatr Soc. 2010. PMID: 21087225 Free PMC article.

9

Successful eculizumab treatment of recurrent postpartum atypical hemolytic uremic syndrome after kidney transplantation.

Garlo K, Dressel D, Savic M, Vella J. Garlo K, et al. Clin Nephrol Case Stud. 2015 Jun 15;3:8-13. doi: 10.5414/CNCS108491. eCollection 2015. Clin Nephrol Case Stud. 2015. PMID: 29043127 Free PMC article.

10

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.

Barbour T, Scully M, Ariceta G, Cataland S, Garlo K, Heyne N, Luque Y, Menne J, Miyakawa Y, Yoon SS, Kavanagh D; 311 Study Group Members. Barbour T, et al. Kidney Int Rep. 2021 Mar 24;6(6):1603-1613. doi: 10.1016/j.ekir.2021.03.884. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page